Common use of Manufacturing Capacity Clause in Contracts

Manufacturing Capacity. ALLERGAN undertakes to ensure that it has at all times sufficient Manufacturing capacity at the Manufacturing Facilities to satisfy GSK's Product requirements set out in the Rolling Forecasts. (a) ALLERGAN shall routinely monitor the Manufacturing capacity available to GSK at the Manufacturing Facilities, such that ALLERGAN shall make appropriate changes to its utilization of such capacity to satisfy GSK's requirements of Product in accordance with this Supply Agreement. (b) GSK and ALLERGAN shall review and discuss the Manufacturing capacity available at the Manufacturing Facilities in relation to the Rolling Forecast as part of the regular review meetings pursuant to Section 2.6. (c) In the event of a break or fault in production that can reasonably be foreseen to affect supply of Product to GSK, ALLERGAN shall notify GSK promptly if such fault cannot be remedied within five (5) business days and, following such notification, will keep GSK apprised of the status of the remedial action to be taken by ALLERGAN. ALLERGAN shall in any event use its best endeavors to ensure a return to production as soon as possible.